![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 28, 2012 1:35:22 AM
http://www.reuters.com/article/2012/03/26/us-illumina-columbia-idUSBRE82P0VK20120326
By Jonathan Stempel
Mon Mar 26, 2012 1:41pm EDT
(Reuters) - Illumina Inc, a gene-mapping company facing a $5.7 billion hostile takeover bid by Swiss drugmaker Roche Holding AG, was sued by Columbia University on Monday for allegedly infringing five patents related to DNA sequencing.
According to the complaint filed in the U.S. District Court in Wilmington, Delaware, Illumina commercialized its so-called next-generation sequencing (NGS) products despite knowing about the patents, obtained between 2009 and 2012 and assigned to Columbia.
The university said its patents cover NGS technologies that allow rapid and precise DNA sequencing, which are particularly important in using individuals' genomic DNA sequence information as a basis for providing health care.
Each patent has several inventors, including Columbia chemical engineering professor Jingyue Ju, according to the complaint. The university is seeking royalties, triple damages and other remedies.
Illumina makes products that decode a person's entire genome. "We believe these claims are without merit and we will defend against them vigorously," Illumina spokeswoman Jennifer Temple said in a statement about the lawsuit.
It is unclear whether Columbia might have similar claims against other companies.
"Columbia is proud of the outstanding research efforts of its faculty and will defend its patented technology," university spokesman Robert Hornsby said. He declined to comment about other potential claims.
The university filed its complaint hours after Roche extended its cash takeover bid for Illumina.
Roche's bid values Illumina at $44.50 per share, but the San Diego-based company said the offer is "grossly inadequate."
Acquiring the company would give Basel, Switzerland-based Roche a leading position in gene sequencing, which could help better identify patients who might benefit from using particular drugs.
Illumina in 2011 posted profit of $86.6 million on revenue of $1.06 billion.
In its annual report, the company projected that expansion in the sequencing market and its product portfolio would drive demand for its technology over the next several years.
Analysts expect Roche to raise its takeover bid, and shares of Illumina have traded above $44.50 since the original bid became public on January 25.
In afternoon trading, Illumina shares were down 15 cents at $50.31 on the Nasdaq.
The case is Trustees of Columbia University in the City of New York v. Illumina Inc, U.S. District Court, District of Delaware, No. 12-00376.
(Reporting By Jonathan Stempel in New York; Additional reporting by Caroline Copley in Zurich; editing by John Wallace and Gerald E. McCormick)
Recent ILMN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:29:30 PM
- Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations • PR Newswire (US) • 06/11/2024 01:15:00 PM
- Apple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More News • IH Market News • 06/10/2024 11:29:44 AM
- KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 • PR Newswire (US) • 06/07/2024 10:09:00 PM
- Apollo Buys 49% of Intel’s Irish Plant for $11bn, BlackRock and Citadel to Create Texas Exchange, and More News • IH Market News • 06/05/2024 11:41:36 AM
- Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost • PR Newswire (US) • 06/04/2024 01:15:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:22:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:25:32 PM
- Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares • PR Newswire (US) • 06/03/2024 09:22:00 PM
- Illumina appoints Everett Cunningham Chief Commercial Officer • PR Newswire (US) • 06/03/2024 11:11:00 AM
- Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO • PR Newswire (US) • 05/29/2024 01:15:00 PM
- Illumina releases 2023 Corporate Social Responsibility Report • PR Newswire (US) • 05/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:22:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:12:50 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/20/2024 08:27:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:09:18 PM
- Anna Richo joins Illumina's Board of Directors • PR Newswire (US) • 05/20/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:23:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:18:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:17:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:16:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:10:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:08:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:05:13 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM